Karnataka High Court Refuses To Quash Substandard Drug Case, Says Allegations Bear Directly On Public Health

3 min read

Can a substandard drug case be thrown out because a sample took two days to reach the laboratory? Not at this stage, the Karnataka High Court has said, refusing to quash the prosecution of a Himachal Pradesh pharma firm and its managing partner over Calcium and Vitamin D3 tablets declared not of standard quality.

Karnataka High Court building, which refused to quash a substandard drug case against a pharma firm and its managing partner.

Bengaluru: The Karnataka High Court has refused to quash criminal proceedings under the Drugs and Cosmetics Act, 1940 against M/s Life Vision Healthcare and its managing partner over Calcium and Vitamin D3 tablets that were declared “Not of Standard Quality” [M/s Life Vision Healthcare & Anr. v. State of Karnataka].

Justice Rajesh Rai K dismissed Criminal Petition No. 1600 of 2024 by an oral order dated November 2, 2026. The petitioners, the Baddi-based firm and its managing partner Naveen Kumar Bansal, accused Nos. 1 and 2, had sought quashing of C.C. No. 43 of 2023 pending before the Special Court for Economic Offences, Bengaluru, for an alleged violation of Section 18(a)(i), punishable under Section 27(d) of the Act. The complaint was lodged at the instance of the Assistant Drugs Controller, Bengaluru Circle-1.

The two-day gap and the word “forthwith”

The sample was seized on February 18, 2020 and sent for chemical analysis on February 20, 2020. The petitioners argued that this two-day interval breached Section 23(4)(i) of the Act and prejudiced their statutory right to have the sample re-tested by the Central Drugs Laboratory. The Court answered that “forthwith” does not require immediate dispatch without completing the other procedural steps the Act prescribes:

“Forwarding the seized drug sample for chemical analysis within two days cannot, in the facts and circumstances of the present case, be construed as an undue or unexplained delay.”

What the tests showed

At the centre of the case are “Impcal Tablets” (Calcium Orotate with Vitamin D3 Tablets IP), batch LTA-2497, which the firm manufactured in September 2019. The analysis declared the sample “Not of Standard Quality”, specifically on the Vitamin D3 assay.

The firm was informed of the adverse report on August 28, 2020, but asked for re-analysis only on April 15, 2021. By then the drug’s shelf life had run out in February 2021.

The partner and his designation

Another plank of the petition was that the managing partner was being prosecuted merely because of his designation. The Court did not accept this. On its reading, the averments in the private complaint prima facie indicated that he was actively involved in the affairs and day-to-day functioning of the firm, and the judgments the petitioners relied on were distinguishable on facts.

Declining to interfere, the Court held:

“…prima facie reveals, there is serious allegations have been made against the petitioners regarding the manufacture and sale of drugs which were found to be not of standard quality. The allegations, if established, have a direct bearing on public health and cannot be lightly brushed aside at this stage. The matter, therefore, warrants a full-fledged trial, wherein the respective parties will have an opportunity to establish their case in accordance with law.”

All contentions remain open to the petitioners before the trial court. The High Court stressed that it was expressing no opinion on the merits. The allegations are yet to be tested at trial, and the accused are presumed innocent until proven guilty.

Why the order matters

Manufacturers facing drug-quality prosecutions often seek quashing on procedural timelines under Section 23 of the Drugs and Cosmetics Act. The order reads “forthwith” practically and signals that where public health is at stake, such objections, along with the role of firm officials, are matters for trial rather than a quashing petition.

Case Title: M/s Life Vision Healthcare & Anr. v. State of Karnataka
Case Number: Criminal Petition No. 1600 of 2024; NC: 2026:KHC:60798
Bench: Justice Rajesh Rai K, Karnataka High Court
Date of Order: November 2, 2026
Appearances: Advocates Nitin Bhasir and Uday Urs for the petitioners; HCGP Mahesha P for the State

Similar Posts